Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nightingale: QLS-111 vs Timolol in Normal Tension Glaucoma
NCT06030193Phase 2Completed
- Start
- Aug 2025
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of QLS-111 in normal tension glaucoma (NTG). Started Aug 2025; status: completed.
02
Drugs
QLS-111
03
Conditions
normal tension glaucoma (NTG)
Beyond the preview
Go deeper on NCT06030193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06030193.